NEW DELHI: Health experts have raised concerns over India's emergency approval of a coronavirus vaccine by local firm Bharat Biotech before the completion of trials.

Expressing shock over the approval, Health watchdog All India Drug Action Network said there are intense concerns arising from the absence of the efficacy data as well a lack of transparency that would raise more questions.